08/26/2025 5:24 AM | Oragenics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/11/2025 7:30 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2025 3:16 PM | Oragenics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/02/2025 3:30 PM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2025 7:15 AM | Oragenics (Filer)
| Form 424B5 | |
06/30/2025 11:15 PM | Oragenics (Filer)
| Form EFFECT | |
06/30/2025 12:28 PM | Oragenics (Filer)
| Form S-1/A | |
06/23/2025 5:18 AM | Oragenics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
06/16/2025 4:54 PM | Odyssey Health, Inc. (Reporting) Oragenics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/16/2025 5:01 PM | Odyssey Health, Inc. (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2025 2:09 PM | Odyssey Health, Inc. (Reporting) Oragenics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for OGEN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.
|
05/28/2025 6:00 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2025 4:10 PM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2025 7:30 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2025 3:30 PM | Oragenics (Filer)
| Form DEF 14A | |
03/27/2025 7:30 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2025 8:15 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/18/2025 3:30 PM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2025 7:00 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:05 PM | Oragenics (Filer)
| Form RW | |
01/21/2025 7:00 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2025 11:15 PM | Oragenics (Filer)
| Form EFFECT | |
01/08/2025 5:06 AM | Oragenics (Filer)
| Form S-1/A | |
12/31/2024 10:47 AM | Oragenics (Filer)
| Form S-1/A | |
12/19/2024 9:00 AM | Oragenics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/16/2024 3:05 PM | Oragenics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/16/2024 3:10 PM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2024 5:07 PM | DUNTON ALAN W (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2024 3:23 PM | Oragenics (Issuer) Telling Fred (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2024 3:35 PM | Oragenics (Subject) Telling Fred (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024 1:04 PM | DUNTON ALAN W (Reporting) Oragenics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024 4:00 PM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 6:29 PM | Lind Global Fund II LP (Filed by) Oragenics (Subject)
| Form SC 13G/A | |
11/13/2024 1:40 PM | Oragenics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024 8:20 AM | Oragenics (Filer)
| Form DEFA14A | |
10/31/2024 8:15 AM | Oragenics (Filer)
| Form DEF 14A | |
10/18/2024 7:30 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 9:30 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2024 5:25 PM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2024 3:45 PM | Oragenics (Filer)
| Form 424B5 | |
10/09/2024 6:30 AM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
09/20/2024 8:15 PM | Oragenics (Issuer) Telling Fred (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | Murphy Kimberly M (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | Cassidy Bruce A. Sr. (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | KOSKI ROBERT C (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | DUNTON ALAN W (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | GANDOLFO JOHN P (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | Oragenics (Issuer) POPE CHARLES L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | Oragenics (Issuer) REDMOND J MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 8:15 PM | Huffman Janet (Reporting) Oragenics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:45 AM | Iroquois Capital Management, LLC (Filed by) Oragenics (Subject)
| Form SC 13G | |
09/05/2024 3:45 PM | Oragenics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 7:26 AM | Oragenics (Filer)
| Form 424B5 | |
09/03/2024 11:15 PM | Oragenics (Filer)
| Form EFFECT | |